Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump
暂无分享,去创建一个
C. Spreafico | F. Garbagnati | C. Spreafico | F. Garbagnati | P. Tralongo | Bruno Damascelli | A. Marchianò | R. Lutman | M. Salvetti | M. G. Bonalumi | M. Mauri | A. Del Nero | G. Comeri | G. Conti | S. Coppoli | G. Benetti | P. Tralongo | D. Belussi | G. Comeri | G. Conti | B. Damascelli | M. Salvetti | R. Lutman | D. Belussi | M. Mauri | A. Del Nero | Via G. Venezian | I. Da Milano | M. G. Bonalumi | G. Benetti | A. del Nero | A. Marchiano | S. Coppoli | Istituto Nazionale | MD Bruno Damascelli | MD A. Marchianb | MD C. Spreafico | MD R. Lutman | MD M. Salvetti | MD M. G. Bonalumi | MD M. Mauri | MD F. Garbagnati | MD A. Del Nero | MD T G. Comeri | MD G. Conti | MD S. Coppoli | MD G. Benetti | MDlT P. Tralongo | MDt D. Belussi | I33 Milano
[1] W. Hrushesky,et al. Circadian-based infusional chrono-chemotherapy controls progressive metastatic renal cell carcinoma. , 1988, Seminars in surgical oncology.
[2] P D Schneider,et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. , 1987, Annals of surgery.
[3] E. McFadden,et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.
[4] Hrushesky Wj,et al. Circadian pattern of continuous FUDR infusion reduces toxicities. , 1987 .
[5] S. Krown. Therapeutic options in renal-cell carcinoma. , 1985, Seminars in oncology.
[6] G. Sufrin. The challenges of renal adenocarcinoma. , 1982, The Surgical clinics of North America.
[7] M. Greenberg,et al. Inhibition of angiotensin-converting enzyme in congestive heart failure. , 1987, The New England journal of medicine.
[8] D. Hutchison,et al. The physiologic disposition of 5‐fluorouracil and 5‐fluoro‐2′‐deoxyuridine in man , 1964, Clinical pharmacology and therapeutics.
[9] J. Dekernion,et al. Treatment of advanced renal cell carcinoma--traditional methods and innovative approaches. , 1983, The Journal of urology.
[10] M J Ratain,et al. A programmable and implantable pumping system for systemic chemotherapy: a performance analysis in 52 patients. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] F. Holmes,et al. Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] J. Richie,et al. Phase I/II study of recombinant interferon gamma in advanced renal cell carcinoma. , 1988, The Journal of urology.